G. Navis

发表

Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease.

D. de Zeeuw, P. D. de Jong, A. Boonstra, 2001, Seminars in nephrology.

Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria.

R. Henning, G. Navis, G. Laverman, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.

P. van Paassen, D. de Zeeuw, P. D. de Jong, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.

G. Navis, D. de Zeeuw, P. D. de Jong, 2000, Journal of the American Society of Nephrology : JASN.

A method for accurate measurement of GFR in conscious, spontaneously voiding rats.

G. Navis, D. de Zeeuw, P. D. de Jong, 1997, Kidney international.

Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?

P. van Paassen, D. de Zeeuw, P. D. de Jong, 1996, Hypertension.

The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.

G. Navis, D. de Zeeuw, P. D. de Jong, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

CARDIOVASCULAR Changes in glomerular ﬁltration rate after cardiac surgery with cardiopulmonary bypass in patients with mild preoperative renal dysfunction

R. Henning, A. Epema, W. Oeveren, 2008 .

Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.

D. Zeeuw, D. de Zeeuw, P. D. de Jong, 1996, Clinical science.

Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.

D. Zeeuw, D. de Zeeuw, H. Hillege, 2000, Journal of the American Society of Nephrology : JASN.

Can continuous intraperitoneal infusion of 125I-iothalamate and 131I-hippuran be used for measurement of GFR in conscious rats?

D. de Zeeuw, P. D. de Jong, P. de Vries, 1998, Renal failure.

Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats.

D. de Zeeuw, P. D. de Jong, P. de Vries, 1999, Journal of cardiovascular pharmacology.

Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats.

G. Navis, D. de Zeeuw, P. D. de Jong, 1999, Journal of the American Society of Nephrology : JASN.

Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activity.

D. de Zeeuw, P. D. de Jong, W. V. van Gilst, 1998, Journal of pharmacological and toxicological methods.

Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.

H. Parving, G. Navis, D. de Zeeuw, 2000, Kidney international. Supplement.

Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function

D. de Zeeuw, P. D. de Jong, A. Woittiez, 1999, European Journal of Clinical Pharmacology.

Renal hemodynamic effects of candesartan in normal and impaired renal function in humans.

D. de Zeeuw, P. D. de Jong, H. Buter, 1997, Kidney international. Supplement.

Metabolic aspects of dietary sodium restriction as a therapeutic intervention

S. Bakker, A. Lely, G. Navis, 2010 .

ABSENCE OF CROSS-REACTIVITY BETWEEN CAPTOPRIL AND ENALAPRIL

D. Zeeuw, D. Zeeuw, C. Kallenberg, 1984, The Lancet.

Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?

D. Zeeuw, G. Navis, D. de Zeeuw, 1998, Journal of the American Society of Nephrology : JASN.

Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.

D. Grobbee, D. Zeeuw, G. Navis, 2003, European heart journal.

The emerging role of ACE2 in physiology and disease†

R. Korstanje, N. Hooper, M. Cooper, 2007, The Journal of pathology.

Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

R. Gans, H. Hillege, S. Bakker, 2012, Diabetologia.

Enalapril and the kidney. Clinical studies of the renal effects of enalapril in antihypertensive treatment.

G. Navis, G. Navis, 1988, Pharmaceutisch weekblad. Scientific edition.

Endogenous Plasma Erythropoietin, Cardiovascular Mortality and All‐Cause Mortality in Renal Transplant Recipients

R. Gans, J. J. Homan van der Heide, S. Bakker, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage.

G. Navis, H. van Goor, A. Lely, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Glomerular and tubular induction of the transcription factor c‐Jun in human renal disease

G. Navis, R. Kok, H. van Goor, 2007, The Journal of pathology.

ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats

H. van Goor, I. Hamming, G. Navis, 2006, The Journal of pathology.

ACE Inhibition Preserves Heparan Sulfate Proteoglycans in the Glomerular Basement Membrane of Rats with Established Adriamycin Nephropathy

D. Zeeuw, D. de Zeeuw, P. D. de Jong, 2000, Nephron Experimental Nephrology.

Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.

D. Zeeuw, G. Navis, D. de Zeeuw, 1999, Journal of pharmacological and toxicological methods.

Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis.

I. Hamming, G. Navis, V. Goor, 2007, Kidney international.

Local Medial Microenvironment Directs Phenotypic Modulation of Smooth Muscle Cells After Experimental Renal Transplantation

Kiran K. Katta, G. Navis, R. Goldschmeding, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Gender‐specific correlations of plasminogen activator inhibitor‐1 and tissue plasminogen activator levels with cardiovascular disease‐related traits

J. H. Moore, G. Navis, H. Hillege, 2007, Journal of thrombosis and haemostasis : JTH.

11b‐hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin‐II receptor blockade

R. Dullaart, R. Dullaart, G. Navis, 2002 .

Renal disease in POEMS syndrome: report on a case and review of the literature.

E. Vellenga, G. Navis, P. D. de Jong, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Nephrectomy Elicits Impact of Age and BMI on Renal Hemodynamics: Lower Postdonation Reserve Capacity in Older or Overweight Kidney Donors

J. J. H. Heide, G. Navis, M. Rook, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Postoperative renal dysfunction and preoperative left ventricular dysfunction predispose patients to increased long-term mortality after coronary artery bypass graft surgery.

A. Epema, C. Stegeman, G. Navis, 2009, British journal of anaesthesia.

Concordance of dietary sodium intake and concomitant phosphate load: Implications for sodium interventions.

G. Navis, A. Kwakernaak, G. Laverman, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

OBESITY AND THE KIDNEY

G. Wolf, G. Navis, R. Bosma, 2006 .